Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.67 |
| ▸ | FASN | P49327 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | TERT | O14746 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2785794 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL7806557 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL6556128 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL1614406 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL3793137 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL23067684 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL17540751 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL2453148 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL21411170 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 | |
| SCHEMBL1614408 | 1.00 | PTPN1 (0.67) | PTPN1FASNKDM4ECNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110325605-A | Ultraviolet cured paint composition based on biomaterial | 乐金华奥斯株式会社 | 2019-10-11 | — | — | CN | claimed |
| US-7968737-B2 | Producing method of phospholipids including long-chain polyunsaturated fatty acids as constituents, and use of such phospholipids | SUNTORY HOLDINGS LIMITED (JP) | 2011-06-28 | — | — | US | claimed |
| US-20100317622-A1 | Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids | SUNTORY HOLDINGS LIMITED (JP) | 2010-12-16 | — | — | US | claimed |
| EP-1392621-B1 | SOLID PHASE EXTRACTION METHOD FOR OBTAINING HIGH-PURITY UNSATURATED COMPOUNDS OR DERIVATIVES OF SAID COMPOUNDS | NUTRINOVA GMBH (DE) | 2010-10-13 | — | — | EP | claimed |
| US-7365219-B2 | Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds | NUTRINOVA NUTRITION SPECIALTIES & FOOD INDREDIENTS GMBH (DE) | 2008-04-29 | — | — | US | claimed |
| US-20080020124-A1 | Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids | SUNTORY HOLDINGS LIMITED (JP) | 2008-01-24 | — | — | US | claimed |
| US-20080020033-A1 | Oil or Fat Compositions Containing Phospholipids and a Long-Chain Polyunsaturated Fatty Acid Supply Compound, and Food Using Same | SUNTORY HOLDINGS LIMITED (JP) | 2008-01-24 | — | — | US | claimed |
| CN-1954079-A | Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same | SUNTORY LTD (JP) | 2007-04-25 | — | — | CN | claimed |
| CN-1890357-A | Fat composition containing phospholipid and long-chain polyunsaturated fatty acid supplying compound and food using the same | SUNTORY LTD (JP) | 2007-01-03 | — | — | CN | claimed |
| EP-1731616-A1 | PROCESS FOR PRODUCING PHOSPHOLIPID CONTAINING LONG CHAIN POLYUNSATURATED FATTY ACID AS CONSTITUENT THEREOF AND UTILIZATION OF THE SAME | SUNTORY LIMITED (JP) | 2006-12-13 | — | — | EP | claimed |
| EP-1710296-A1 | FAT COMPOSITION CONTAINING PHOSPHOLIPID AND LONG-CHAIN POLYUNSATURATED FATTY ACID-SUPPLYING COMPOUND AND FOOD USING THE SAME | SUNTORY LIMITED (JP) | 2006-10-11 | — | — | EP | claimed |
| US-20040162437-A1 | Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds | NUTRINOVA NUTRITION SPECIALIST & FOOD INGREDIENTS GMBH (DE) | 2004-08-19 | — | — | US | claimed |
| EP-0381823-A2 | Cytotropic heterogenous molecular lipids (CHML) and process for preparing the same | Xu, Zheng (CN) | 1990-08-16 | — | — | EP | claimed |
| CN-1042658-A | CHML and preparation method thereof | XU ZHENG (CN) | 1990-06-06 | — | — | CN | claimed |
| US-12545796-B2 | Ink compositions | RICOH COMPANY, LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| EP-4630504-A1 | INK COMPOSITIONS | Ricoh Company, Ltd. (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-20250268814-A1 | SIMULATED VERNIX COMPOSITION AND EMULSION INCLUDING THE SAME | Dermegen Inc. (US) | 2025-08-28 | — | — | US | disclosed |
| CN-1075403-A | Supplementary nourishment | TANISAKE KK (JP) | 1993-08-25 | — | — | CN | disclosed |
| EP-0381823-A2 | Cytotropic heterogenous molecular lipids (CHML) and process for preparing the same | Xu, Zheng (CN) | 1990-08-16 | — | — | EP | disclosed |
| CN-1042658-A | CHML and preparation method thereof | XU ZHENG (CN) | 1990-06-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268814-A1 | SIMULATED VERNIX COMPOSITION AND EMULSION INCLUDING THE SAME | SQLE, LPXN, VIL1 | PTPN1 3325/4885FASN 4/4885KDM4E 1606/4885 |
| US-12545796-B2 | Ink compositions | TYR, ALKBH3, ALKBH1 | PTPN1 1441/4885FASN 3293/4885KDM4E 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.